JPH06296859A - Coated carrier - Google Patents

Coated carrier

Info

Publication number
JPH06296859A
JPH06296859A JP5114268A JP11426893A JPH06296859A JP H06296859 A JPH06296859 A JP H06296859A JP 5114268 A JP5114268 A JP 5114268A JP 11426893 A JP11426893 A JP 11426893A JP H06296859 A JPH06296859 A JP H06296859A
Authority
JP
Japan
Prior art keywords
coated carrier
adsorbent
coating layer
carrier
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5114268A
Other languages
Japanese (ja)
Other versions
JP3353945B2 (en
Inventor
Hajime Yoshida
一 吉田
Norio Inama
徳生 稲摩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Medical Co Ltd
Original Assignee
Asahi Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Medical Co Ltd filed Critical Asahi Medical Co Ltd
Priority to JP11426893A priority Critical patent/JP3353945B2/en
Publication of JPH06296859A publication Critical patent/JPH06296859A/en
Application granted granted Critical
Publication of JP3353945B2 publication Critical patent/JP3353945B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To provide a coated carrier for an adsorbent which does not have non-singularity adsorption of lipid or protein and fix a large number of ligands easily and stably with a superb compatibility with a body fluid such as blood and an outstanding adsorptive capability. CONSTITUTION:The subject coated carrier consists of a high-molecular coated layer formed on the surface of a solid fibrous film-like porous carrier of an adsorbent made from an organic synthetic high-molecular material.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】溶液、特に体液中の成分を吸着す
るために吸着材が用いられている。本発明は、この吸着
材に有用な多孔質担体に関する。
BACKGROUND OF THE INVENTION Adsorbents are used to adsorb components in solutions, especially body fluids. The present invention relates to a porous carrier useful for this adsorbent.

【0002】[0002]

【従来の技術】溶液中に溶解した物質を吸着するため
に、該物質と親和性のある分子を、多孔質の担体表面に
不溶化した吸着材が、医療、工業等の分野や、分析など
の基礎研究の分野で広く利用されている。この多孔質担
体には、セルロースやデキストラン、キトサン、スチレ
ン・ジビニルベンゼンなどの素材からなる球状あるいは
ビーズ状の多孔質担体が多く利用されている。特に医学
の分野では、病因物質と選択的に結合する分子、即ちリ
ガンドを多孔質の多孔質担体に有する吸着材を用いて、
体外に取り出した患者の血液或いは血漿などの体液を吸
着材と接触させ、血液中の病因物質を吸着除去した後再
度患者に戻す治療法、例えば体外循環治療等で利用され
ている。例えば、セルロース製のビーズ状多孔質担体に
デキストラン硫酸を共有結合したもの、ポリビニルアル
コール製のビーズ状多孔質担体にトリプトファンを共有
結合したもの等である。これらビーズ状の多孔質担体は
細密充填が難しく、プライミングボリュームが大きいな
どの問題点があった。この問題点を解決する目的で、繊
維状の多孔質吸着材が知られている(特開昭60−24
6765)。該発明に示された繊維状の多孔質吸着材
は、上記ビーズ状担体を用いた吸着材の問題点を解決し
たものであったが、本発明者らの研究によると、多孔質
ガラス繊維等の該発明の多孔質担体は脂質や蛋白質など
の非特異吸着が多く、リガンドを表面に固定して選択的
或いは特異的吸着材としての使用には不適であった。更
に表面への官能基の導入が困難で、導入できる官能基の
種類も限られるため汎用性がなく、よってリガンドを安
定に固定する担体として問題があった。また、吸着材単
位容積当たりの被吸着物質の吸着量、即ち吸着性能は多
孔質支持体が被吸着物質の接触・吸着可能な表面積を如
何に多く有しているかによって決まる。該表面積は吸着
材担体の外部表面積と内部表面積の和であるが、従来ビ
ーズ状担体では内部表面積を大きくする目的で孔径を大
きくする、或いは孔数を増やすなどが成されているが、
ビーズ状担体で得られる孔は本発明とは異なり実質的に
は貫通せず、表面から内部にいくにつれ小さくなるので
孔内に吸着した被吸着物質によって封鎖され、それ以上
の被吸着物質を含む体液は流入できない或いは、内部に
入り込む被吸着物質を含む体液は拡散によるもので限度
がある、等の問題点があった。また、外部表面積を大き
くする目的でビーズ状担体の粒子径を小さくすると通液
抵抗が大となり、さらには粒子がカラム外へ流出する恐
れもあり危険である。つまり有効に使うことができる表
面積の増大には限度があった。
2. Description of the Related Art In order to adsorb a substance dissolved in a solution, an adsorbent in which a molecule having an affinity for the substance is insolubilized on the surface of a porous carrier is used in the fields of medicine, industry, analysis, etc. Widely used in the field of basic research. As the porous carrier, spherical or bead-shaped porous carriers made of materials such as cellulose, dextran, chitosan, and styrene / divinylbenzene are often used. Particularly in the medical field, a molecule that selectively binds to a pathogen, that is, an adsorbent having a ligand in a porous carrier is used,
It is used in a treatment method, for example, an extracorporeal circulation treatment, in which a body fluid such as blood or plasma of a patient taken out of the body is brought into contact with an adsorbent to adsorb and remove a pathogenic substance in blood and then returned to the patient. For example, a bead-like porous carrier made of cellulose and covalently bound dextran sulfate, a bead-like porous carrier made of polyvinyl alcohol and tryptophan covalently bonded thereto, and the like. These bead-shaped porous carriers have problems that it is difficult to pack them closely and the priming volume is large. For the purpose of solving this problem, a fibrous porous adsorbent is known (JP-A-60-24).
6765). The fibrous porous adsorbent shown in the invention solves the problems of the adsorbent using the above bead-shaped carrier, but according to the study of the present inventors, porous glass fiber etc. Since the porous carrier of the present invention has a large amount of nonspecific adsorption of lipids and proteins, it was unsuitable for use as a selective or specific adsorbent by immobilizing a ligand on the surface. Furthermore, since it is difficult to introduce a functional group onto the surface and the types of functional groups that can be introduced are limited, there is no versatility, and there is a problem as a carrier for stably immobilizing a ligand. Also, the amount of adsorbed substance adsorbed per unit volume of adsorbent, that is, the adsorption performance is determined by how much surface area the porous support can contact and adsorb the adsorbed substance. The surface area is the sum of the external surface area and the internal surface area of the adsorbent carrier, but in the conventional bead-shaped carrier, the pore diameter is increased or the number of pores is increased in order to increase the internal surface area.
Unlike the present invention, the pores obtained with the bead-shaped carrier do not substantially penetrate, and become smaller from the surface to the inside, so that the pores are blocked by the adsorbed substance adsorbed in the pores and contain more adsorbed substances. There is a problem that the body fluid cannot flow in, or the body fluid containing the substance to be adsorbed that enters the body is limited due to diffusion. Further, if the particle diameter of the bead-shaped carrier is reduced for the purpose of increasing the external surface area, the liquid resistance becomes large, and further, the particles may flow out of the column, which is dangerous. In other words, there is a limit to the increase in surface area that can be effectively used.

【0003】[0003]

【発明が解決しようとする課題】本発明の目的は、脂質
や蛋白質の非特異吸着がなく、血液などの体液との適合
性に優れ、多くのリガンドを容易且つ安定に固定でき、
吸着能力に優れた吸着材用の被覆担体を提供するにあ
る。
The object of the present invention is to achieve non-specific adsorption of lipids and proteins, excellent compatibility with body fluids such as blood, and easy and stable immobilization of many ligands.
It is intended to provide a coated carrier for an adsorbent having excellent adsorption ability.

【0004】[0004]

【課題を解決するための手段】本発明の要旨は下記のと
おりのものである。有機合成高分子材料からなる吸着材
用の中実繊維膜状多孔質担体の表面に高分子被覆層を有
することを特徴とする被覆担体。以下に、本発明を項目
別に説明する。
The gist of the present invention is as follows. A coated carrier having a polymer coating layer on the surface of a solid fiber membrane-like porous carrier for an adsorbent made of an organic synthetic polymer material. The present invention will be described below item by item.

【0005】内部表面積の定義 多孔質担体内の全孔の表面積の総和を言う。Definition of internal surface area: The total surface area of all pores in a porous carrier.

【0006】被覆担体の定義 本発明でいう被覆担体とは、目的とする物質と親和性の
ある分子、即ちリガンドを表面に不溶化することによっ
て吸着材とするための、表面に開孔した多くの細孔を有
する多孔質の担体であって、太さに対して長手方向の長
さが十分に長い、糸状或いは繊維状の中実繊維膜状多孔
質支持体表面を親水性材料で被覆処理した物を言う。被
覆担体は、断面の形状が円、楕円、多角形状、星形等い
ずれの形状であっても良い。更に断面中央部に、長手方
向に沿って実質的に同一形状で貫通した孔を有さない。
ここで言う断面中央部に、長手方向に沿って実質的に同
一形状で貫通した孔とは、中空糸膜が有する、例えば紡
糸時に連続的に形成される、中空糸外部と膜で隔てられ
た内部空間等を指し、細孔の連続によって不規則に形成
されたものをいわない。
Definition of coated carrier The coated carrier as referred to in the present invention means a large number of pores opened on the surface for making an adsorbent by insolubilizing a molecule having an affinity for a target substance, that is, a ligand. A porous carrier having pores, the length of which in the longitudinal direction is sufficiently long with respect to the thickness, and the surface of a thread-like or fibrous solid fiber membrane porous support is coated with a hydrophilic material. Say something. The coated carrier may have a cross section of any shape such as a circle, an ellipse, a polygon, and a star. Furthermore, the central portion of the cross section does not have a hole penetrating in a substantially same shape along the longitudinal direction.
The hole penetrating in the central part of the cross section along the longitudinal direction with substantially the same shape is separated by the membrane from the outside of the hollow fiber, which the hollow fiber membrane has, for example, is continuously formed during spinning. Refers to the internal space, etc., and does not refer to those formed irregularly by the continuity of pores.

【0007】親水性被覆層の定義 本発明でいう親水性被覆層とは、水溶液や血液との親和
性をよくするために、中実繊維膜状多孔質支持体を実質
的に覆う親水性の重合体であって、接触角測定法によっ
て求められる平板状にした時の表面の水滴の接触角が8
0度以下であるものが好ましく、重合体を重合体単位の
単量体としての名前で例示すれば、ヒドロキシスチレ
ン、ヒドロキシメチルスチレン、ビニルアルコール、2
−ヒドロキシエチルアクリレート、2−ヒドロキシエチ
ルメタクリレート、ビニルアミン、ジエチルアミノエチ
ルスチレン、ジエチルアミノエチルメタクリレート、メ
トキシトリエチレングリコールメタクリレート、ジメチ
ルアミノエチル(メタ)アクリレートセグメント化ポリ
ウレタン、セグメント化ポリエステル等のブロック共重
合体、ポリエチレンオキサイド鎖を有する単量体と他の
重合単量体のようなグラフト共重合体、エチレン−ビニ
ルアルコール、ポリエステル、ポリエチレングリコー
ル、等が例示できる。
Definition of hydrophilic coating layer The hydrophilic coating layer as used in the present invention is a hydrophilic coating layer that substantially covers the solid fibrous membrane-like porous support in order to improve the affinity with an aqueous solution or blood. It is a polymer, and the contact angle of water droplets on the surface when formed into a flat plate, which is determined by the contact angle measurement method, is 8
It is preferably 0 degree or less, and when the polymer is exemplified by the name as a monomer of the polymer unit, hydroxystyrene, hydroxymethylstyrene, vinyl alcohol, 2
-Hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, vinylamine, diethylaminoethylstyrene, diethylaminoethyl methacrylate, methoxytriethylene glycol methacrylate, dimethylaminoethyl (meth) acrylate segmented polyurethane, segmented polyester and other block copolymers, polyethylene oxide Examples include graft copolymers such as chain-containing monomers and other polymerized monomers, ethylene-vinyl alcohol, polyesters, polyethylene glycols, and the like.

【0008】特に重合体中にヒドロキシル基を有してい
ることが好ましい。ヒドロキシル基の重合体中における
結合様式に特に制限はない。これらの重合体の内、エチ
レン−ビニルアルコール、ポリエチレングリコール、メ
トキシトリエチレングリコールメタクリレートが親水性
の効果の点で好ましく、特にエチレン−ビニルアルコー
ルが塩基性官能基の導入に際して活性基を導入し易く、
且つ塩基性官能基導入時に剥離による親水性の低下が少
ないためより好ましい。親水性被覆層は、上記重合体単
位の単独重合体であってもよく、或いは2つ以上の共重
合体であっても良く、線状重合体、グラフト重合体、架
橋重合体などの重合形態には特に関係はない。
It is particularly preferred that the polymer has a hydroxyl group. There is no particular limitation on the bonding mode of the hydroxyl group in the polymer. Among these polymers, ethylene-vinyl alcohol, polyethylene glycol, methoxytriethylene glycol methacrylate is preferable in terms of hydrophilic effect, particularly ethylene-vinyl alcohol is easy to introduce an active group when introducing a basic functional group,
In addition, the hydrophilicity is less likely to decrease due to peeling when the basic functional group is introduced, which is more preferable. The hydrophilic coating layer may be a homopolymer of the above polymer units, or may be a copolymer of two or more polymers, and may be a polymer such as a linear polymer, a graft polymer or a crosslinked polymer. Has nothing to do with.

【0009】被覆層を得る方法 多孔質支持体に親水性被覆層を得る方法には、被覆層を
形成する化合物を溶解した液中に多孔質支持体を浸漬、
或いは該液を噴霧することによってコーティングする方
法、放射線や電子線を用いたグラフト法により多孔質支
持体表面に共有結合する方法、或いは化学的方法により
多孔質支持体表面の官能基を介して共有結合する方法な
どがある。この中で特にコーティングする方法が工業的
に容易に行なえ、有利である。ここで言うコーティング
法は、被覆層を形成する化合物中に重合性化合物も共存
させ、コーティング後に架橋させるものであってもよ
い。こうして得られた被覆層の量、即ち被覆量は、被覆
担体表面積あたりの被覆層の重量で現す時、10-5g/
2 以上で且つ1g/m2 以下である。被覆量が10-5
g/m2 未満では親水化が不十分で、親水性被覆層とし
ての効果が得られず、又、被覆量が1g/m2 を超える
と支持体の細孔を詰まらせ、多孔質担体として使用でき
なくなってしまうため、好ましくない。この被覆層の特
に好ましい量は10-4g/m2 以上10-1g/m2 以下
である。
Method for Obtaining Coating Layer A method for obtaining a hydrophilic coating layer on a porous support is to immerse the porous support in a liquid in which the compound forming the coating layer is dissolved,
Alternatively, a method of coating by spraying the liquid, a method of covalently bonding to the surface of the porous support by a graft method using radiation or an electron beam, or a method of chemical sharing through a functional group on the surface of the porous support There are ways to combine them. Among them, the coating method is industrially easy and advantageous. The coating method referred to here may be a method in which a polymerizable compound is also allowed to coexist in the compound forming the coating layer and crosslinking is performed after coating. The amount of the coating layer thus obtained, that is, the coating amount, is expressed by the weight of the coating layer per the surface area of the coated carrier, and is 10 −5 g /
It is at least m 2 and at most 1 g / m 2 . The coating amount is 10 -5
If it is less than g / m 2 , hydrophilicity is insufficient and the effect as a hydrophilic coating layer cannot be obtained. If the coating amount is more than 1 g / m 2 , the pores of the support are clogged to give a porous carrier. It is not preferable because it cannot be used. A particularly preferred amount of this coating layer is 10 -4 g / m 2 or more and 10 -1 g / m 2 or less.

【0010】孔径 被覆担体の細孔径と細孔容積は水銀圧入法により水銀圧
曲線から得られる。ここで言う細孔は、できるだけ実用
時に近い状態での値であることが良く、吸着材としての
使用形態時の値をいう。又、水銀圧入法での測定時の乾
燥処理によって形状が変わる場合は、被覆担体径の変化
を測定し、表面積は被覆担体径の変化率の2乗、細孔容
積は被覆担体径の3乗倍して補正することとした。即ち
被覆担体径が1/X倍となった時、表面積は1/X2
倍、細孔容積は1/X3 倍となったとする。被覆担体の
平均孔径は、細孔を円筒形であると仮定して全細孔体積
を細孔全表面積によって割り算することによって求めら
れる。この平均孔径はいずれであっても用いることがで
きるが、0.01μm未満では被吸着物質が被覆担体の
内部にまで十分に侵入せず、十分な吸着能力が得られ
ず、又10μmを超えると、強度が下がって変形し易く
なる危険性が増加し、又、おそらく全表面積が小さくな
りやはり十分な吸着能力は得られず、実用上好ましくな
い。好ましい平均孔径は0.01μm以上で且つ10μ
m以下である。0.05μm以上であることが好まし
く、特に0.1μm以上であることが最も好ましい。更
に5μm以下であることがより好ましく、特に2μm以
下であることが最も好ましい。
Pore size The pore size and pore volume of the coated carrier can be obtained from the mercury pressure curve by the mercury intrusion method. It is preferable that the pores referred to here have a value in a state as close to practical use as possible, and a value when used as an adsorbent. Also, if the shape changes due to the drying process during the measurement with the mercury porosimetry, the change in the diameter of the coated carrier is measured, and the surface area is the square of the change rate of the diameter of the coated carrier, and the pore volume is the cube of the diameter of the coated carrier. It was decided to double the correction. That is, when the diameter of the coated carrier becomes 1 / X times, the surface area becomes 1 / X 2
And the pore volume is 1 / X 3 times. The average pore size of the coated carrier is determined by dividing the total pore volume by the total pore surface area, assuming that the pores are cylindrical. Any average pore diameter can be used, but if it is less than 0.01 μm, the substance to be adsorbed does not sufficiently penetrate into the inside of the coated carrier, and a sufficient adsorption ability cannot be obtained, and if it exceeds 10 μm. However, the risk that the strength is lowered and the material is likely to be deformed is increased, and the total surface area is probably small so that a sufficient adsorption capacity cannot be obtained, which is not preferable in practical use. Preferable average pore diameter is 0.01 μm or more and 10 μm
m or less. The thickness is preferably 0.05 μm or more, and most preferably 0.1 μm or more. It is more preferably 5 μm or less, and most preferably 2 μm or less.

【0011】孔形状 細孔は円形、楕円形、短冊形、星形、多角形、不定形、
その他いずれの形状であっても良いが、円形、楕円形、
短冊形であることが、被覆担体内部への被吸着物質の進
入のしやすさの点でより好ましい。更に、いずれの細孔
形状であっても貫通孔であることが、リガンドを支持体
内部にまで均一に不溶化でき、しかも被吸着物質が吸着
材内部にまで容易に進入できるため、非常に好ましい。
Pore shape The pores are circular, elliptical, rectangular, star-shaped, polygonal, amorphous,
It may have any other shape, but it may be circular, oval,
The strip shape is more preferable in terms of the ease with which the substance to be adsorbed enters the inside of the coated carrier. Further, it is highly preferable that the pores are through-holes regardless of the shape of the pores, because the ligand can be uniformly insolubilized even inside the support, and the substance to be adsorbed can easily enter the inside of the adsorbent.

【0012】孔径分布 孔径は、本発明の被覆担体では繊維表面から中心部まで
より均質な孔を得られて、内部まで有効に吸着に利用し
易いため、ビーズ状多孔質担体の様にブロードな孔径分
布にして内部まで有効に利用しようとする試みは特に重
要でない。被覆担体ではシャープな孔径分布にすること
が、有効表面積を吸着材単位容積当たりより多く確保で
きるためより好ましい。このため0.01μm以上10
μm以下の孔径の容積が全細孔容積の40%以上である
ことが好ましく、70%以上の時より好ましい。更には
0.05μm以上5μm以下の孔径の容積が全容積の4
0%以上であることがより好ましい。70%以上の時更
に好ましく、特に80%という非常にシャープな分布で
あることが最も好ましい。
Pore size distribution With the coated carrier of the present invention, more uniform pores can be obtained from the fiber surface to the central portion, and the pores can be effectively used for adsorption to the inside. An attempt to make a pore size distribution and effectively utilize the inside is not particularly important. For the coated carrier, a sharp pore size distribution is more preferable because a larger effective surface area can be secured per unit volume of the adsorbent. Therefore, 0.01 μm or more 10
The volume of pores having a diameter of μm or less is preferably 40% or more of the total pore volume, and more preferably 70% or more. Furthermore, the volume of pores with a diameter of 0.05 μm or more and 5 μm or less is 4
It is more preferably 0% or more. It is more preferably 70% or more, and most preferably a very sharp distribution of 80%.

【0013】全表面積 本発明の被覆担体の乾燥重量に対する全表面積は、特に
1m2 /g以上であることが好ましく、より好ましくは
5m2 /g以上であり、更に好ましくは10m2 /g以
上である。全表面積は大きければ大きいほど吸着能力は
高くなるのは自明であるが、体外循環治療用の吸着材の
多孔質支持体とし用いる場合は、全表面積が大きくなり
過ぎると吸着目的物質以外の物質の非特異吸着も又増加
する危険性が高くなる。特に血液や体液に対して使用す
る場合は共存する有用な微量蛋白質も多く、これらの非
特異吸着量が増加することは好ましくない。よって50
0m2 /g以下であることが好ましく、より好ましくは
300m2 /g以下であり、最も好ましくは150m2
/g以下である。
Total Surface Area The total surface area based on the dry weight of the coated carrier of the present invention is particularly preferably 1 m 2 / g or more, more preferably 5 m 2 / g or more, further preferably 10 m 2 / g or more. is there. Obviously, the larger the total surface area, the higher the adsorption capacity, but when used as a porous support for an adsorbent for extracorporeal circulation treatment, if the total surface area becomes too large, substances other than the adsorption target substance The risk of non-specific adsorption also increases. Particularly when used for blood or body fluid, many useful trace proteins coexist, and it is not preferable that the nonspecific adsorption amount of these proteins increases. Therefore 50
Is preferably 0 m 2 / g or less, and more preferably not more than 300 meters 2 / g, most preferably 150 meters 2
/ G or less.

【0014】孔径、孔径分布、表面積の測定方法 細孔径及び細孔分布は水銀圧入法により、水銀圧入曲線
によって求めることが出来る。また表面積は窒素などの
ガスを用いて、その吸着量より求める事も出来るが、
(BET法)細孔分布と対比した表面積が得られるた
め、細孔径と同様に水銀圧入法によって求める事が好ま
しい。具体的な孔径、孔径分布、表面積の測定は、水銀
ポロシメーター(島津製作所製、マイクロメリティック
ス・ポアサイズ9320)を用いて測定できる。測定結
果はポアプロットシステム(島津製作所社製、9320
−PC2(V1.0))にて分析し、孔径、孔径分布、
表面積を求めることが出来る。この時水銀の圧力範囲は
1〜30,000psiaとした。
Method for Measuring Pore Size, Pore Size Distribution, Surface Area The pore size and pore size can be determined by the mercury intrusion method and the mercury intrusion curve. The surface area can also be calculated from the amount of adsorption using a gas such as nitrogen,
(BET method) Since the surface area can be obtained in comparison with the pore size distribution, it is preferable to determine it by the mercury intrusion method like the pore size. The specific pore diameter, pore diameter distribution, and surface area can be measured using a mercury porosimeter (manufactured by Shimadzu Corporation, Micromeritics Pore Size 9320). Pore Plot System (Shimadzu Corporation, 9320)
-PC2 (V1.0)) to analyze the pore size, pore size distribution,
The surface area can be determined. At this time, the pressure range of mercury was 1 to 30,000 psia.

【0015】細孔容積 被覆担体の全細孔容積は、被覆担体の乾燥重量あたりの
細孔容積の総量で示すと、0.1ml/g以上で且つ5
0ml/g以下であることが好ましい。全細孔容積が
0.1ml/g未満では、実用上有効に働く表面積が少
なくなってしまうため十分な吸着能力が得られない。又
全細孔容積が50ml/gを超えると被覆担体の強度が
低くなり、使用上好ましくない。更に被覆担体の全細孔
容積のより好ましい範囲を示すと、0.5ml/g以上
30ml/g以下であり、より好ましくは1ml/g以
上10ml/g以下である。
Pore Volume The total pore volume of the coated carrier is 0.1 ml / g or more and 5 when expressed as the total amount of the pore volume per dry weight of the coated carrier.
It is preferably 0 ml / g or less. If the total pore volume is less than 0.1 ml / g, the surface area that works effectively in practice will be small, and sufficient adsorption capacity cannot be obtained. If the total pore volume exceeds 50 ml / g, the strength of the coated carrier becomes low, which is not preferable in use. A more preferable range of the total pore volume of the coated carrier is 0.5 ml / g or more and 30 ml / g or less, and more preferably 1 ml / g or more and 10 ml / g or less.

【0016】担体の形状 被覆担体の長手方向の長さは、太さ、即ち径に対して実
質的に長ければ良く特に規定は不要であるが、取扱い性
の点で50mm以上であることが好ましい。径は、細過
ぎると被覆担体が切れ易く取扱い性が悪くなり、太過ぎ
るとおそらく被吸着物質が被覆担体内部に浸入しにくく
なるために吸着能力が低くなってしまうため、断面積を
円に換算した時の直径で1μm以上10mm以下が好ま
しく、10μm以上1mm以下が更に好ましい。特によ
り好ましくは50μm以上300μm以下である。
Shape of Carrier The length in the longitudinal direction of the coated carrier is not particularly limited as long as it is substantially longer than the thickness, that is, the diameter, but it is preferably 50 mm or more from the viewpoint of handleability. . If the diameter is too thin, the coated carrier will be easily cut and the handling will be poor, and if it is too thick, the adsorption ability will probably be low because the substance to be adsorbed will probably not be able to easily penetrate into the coated carrier. The resulting diameter is preferably 1 μm or more and 10 mm or less, more preferably 10 μm or more and 1 mm or less. Particularly preferably, it is 50 μm or more and 300 μm or less.

【0017】支持体材料 被覆担体の支持体に用いられる材料には、支持体自体の
安定性に優れ、溶出物がなく、乾燥・湿潤状態間の形状
変化も少なく、支持体表面へのリガンド固定が種々の方
法で容易且つ効率良く行なえるため、有機合成高分子材
料であることが好ましい。有機合成高分子材料は具体的
にはナイロン6、ナイロン66などのナイロン樹脂、ポ
リアセタール樹脂、ポリカーボネート樹脂、変性ポリフ
ェニレンオキシド樹脂、ポリブチレンテレフタレート、
ポリエチレンテレフタレート、ポリフェニレンスルファ
イド、ジアリルフタレート、ポリイミド、ポリアミドイ
ミド、ポリメチルペンテン、ホリスルフォン、ポリエー
テルスルフォン、ポリアクリレート、ポリエーテルエス
テルケトン、ポリテトラフルオロエチレン、ポリエチレ
ン、ポリプロピレン、ポリ塩化ビニル、ポリスチレン、
フェノール、エポキシ、ポリウレタン、ポリビニルアセ
タール、ビスコース、ABS、エチレンビニルアルコー
ル、ゴムユリア樹脂、セルロース、セルロースアセテー
ト、ポリメテルメタアクリレート等のいずれか或いはこ
れらを含む共重合体が挙げられる。これらの中で中実繊
維膜状への成型のしやすさや好ましい細孔の形成が容易
であること、更には柔軟性の点より、ポリエチレン、ポ
リプロピレン等のポリオレフィン、ポリスルフォン、ポ
リメチルメタアクレリート、セルロースを成分として含
む高分子材料がより好ましく、特にポリエチレン、ポリ
プロピレン等のポリオレフィン系の高分子材料が、短冊
状の貫通孔が得られ最も好ましい。
Support Material The material used for the support of the coated carrier has excellent stability of the support itself, no eluate, little change in shape between dry and wet states, and ligand immobilization on the surface of the support. Since it can be easily and efficiently carried out by various methods, organic synthetic polymer materials are preferable. Specific examples of the organic synthetic polymer material include nylon resins such as nylon 6 and nylon 66, polyacetal resins, polycarbonate resins, modified polyphenylene oxide resins, polybutylene terephthalate,
Polyethylene terephthalate, polyphenylene sulfide, diallyl phthalate, polyimide, polyamide imide, polymethylpentene, hollisulphone, polyether sulfone, polyacrylate, polyether ester ketone, polytetrafluoroethylene, polyethylene, polypropylene, polyvinyl chloride, polystyrene,
Examples thereof include any one of phenol, epoxy, polyurethane, polyvinyl acetal, viscose, ABS, ethylene vinyl alcohol, rubber urea resin, cellulose, cellulose acetate, and polymethacrylate, or a copolymer containing them. Among them, polyolefins such as polyethylene and polypropylene, polysulfone, and polymethylmetaacrylate are easy to form into a solid fiber membrane and easy to form preferable pores, and also from the viewpoint of flexibility. Further, a polymer material containing cellulose as a component is more preferable, and a polyolefin polymer material such as polyethylene or polypropylene is particularly preferable because a strip-shaped through hole can be obtained.

【0018】製造方法 中実繊維膜状多孔質支持体の製造には、特有の温度で分
解して窒素ガス、炭酸ガス等を生じる有機、或いは無機
の発泡剤を用いる発泡剤分解法、蒸発型溶剤を原料段階
で添加混合し、合成時に溶剤を気散発泡させる溶剤気散
法、常態でガス状の発泡剤を機械的に混合気泡させる気
体混入法、重合過程で発生するガスを利用する化学反応
法、可溶性物質を高分子材料中に分散させた後に溶出す
る溶出法、粉末を溶融温度以下の燒結作用で粒子を互い
に結合させる燒結法、湿式相転換法、溶融相分離法、溶
融紡糸延伸開孔法などを用いることができる。この中で
好ましい繊維径の支持体が得やすいことより、湿式相転
換法、溶融相分離法、溶融紡糸延伸開孔法が好ましく、
特に中実繊維膜状の形状を容易に得られること、高分子
材料に溶剤その他の添加物を用いないため残留溶剤など
の問題がないことより、結晶性高分子を溶融紡糸して繊
維状に成形した後、冷延伸により結晶ラメラ間を開裂さ
せ、更に熱延伸により孔径を拡大させて得られるスタッ
クドラメラとミクロフィブリルとからなる多孔質構造を
形成させる延伸開孔法が特に好ましい。細孔がスタック
ドラメラとミクロフィブリルとからなる多孔質構造の
時、多孔質構造内への溶液の流れ抵抗が少なく、よって
中実繊維膜状多孔質支持体内部へのリガンド固定が内部
まで均質に行え、吸着材として内部まで有効に使用でき
るため特に好ましい。
Manufacturing Method For manufacturing the solid fibrous film-like porous support, a foaming agent decomposition method using an organic or inorganic foaming agent that decomposes at a specific temperature to generate nitrogen gas, carbon dioxide gas, etc. Solvent vaporization method, in which a solvent is added and mixed at the raw material stage, and the solvent is vaporized and foamed during synthesis, gas mixing method in which a gaseous foaming agent is mechanically mixed and foamed in the normal state, and chemistry that uses gas generated in the polymerization process Reaction method, elution method in which soluble substance is dissolved in polymer material and then eluted, sintering method in which powder particles are bonded to each other by a sintering action below melting temperature, wet phase conversion method, melt phase separation method, melt spinning drawing An opening method or the like can be used. Among them, the wet phase conversion method, the melt phase separation method, and the melt spinning draw opening method are preferable because a support having a preferable fiber diameter is easily obtained.
In particular, it is easy to obtain a solid fiber film shape, and since no solvent or other additives are used in the polymer material, there is no problem of residual solvent, etc. A stretch-opening method is particularly preferred in which after forming, the crystal lamellae are split by cold stretching and the pore size is further expanded by hot stretching to form a porous structure composed of stacked lamellae and microfibrils. When the pores have a porous structure composed of stacked lamellae and microfibrils, the flow resistance of the solution into the porous structure is low, so that the immobilization of the ligand inside the solid fiber membrane porous support is uniform to the inside. It is particularly preferable because it can be used as an adsorbent and can be effectively used as an adsorbent even inside.

【0019】リガンドの種類 被覆担体は、その被覆担体表面に或いは被覆層を介して
吸着目的物質との親和性を有する物質、即ちリガンドを
不溶化して使用できる。リガンドには吸着目的物質に対
して親和性を有する公知の合成物や、天然物質を使用で
きる。例えば抗低密度リポ蛋白質抗体、トリプトファ
ン、アセチルコリンレセプター由来ポリペプチド、フェ
ニルアラニン、シビレエイ由来ポリペプチド、血液型
(A型、B型)抗原、プロテインA、トリメチルアンモ
ニウム基、ジメチルアンモニウム基、アスパルテーム、
ポリミキシンB、抗免疫グロブリン抗体、抗CD8抗体
や抗CD4抗体等の抗白血球分化抗原抗体、抗癌壊死因
子抗体等の抗サイトカイン抗体、抗エンドトキシン抗
体、一本鎖或いは2本鎖DNA等である。更にこれらの
内、2種以上のリガンドが不溶化されていても良い。こ
れらのリガンドの分子量はいずれの分子量のものであっ
ても良いが、実用性の点より1,000,000以下が
利用しやすい。
Kind of Ligand The coated carrier can be used by insolubilizing a substance having an affinity for the target substance to be adsorbed, that is, the ligand, on the surface of the coated carrier or through the coating layer. As the ligand, a known synthetic compound having an affinity for the adsorption target substance or a natural substance can be used. For example, anti-low density lipoprotein antibody, tryptophan, acetylcholine receptor-derived polypeptide, phenylalanine, Torpedo-derived polypeptide, blood group (A type, B type) antigen, protein A, trimethylammonium group, dimethylammonium group, aspartame,
Examples thereof include polymyxin B, anti-immunoglobulin antibody, anti-leukocyte differentiation antigen antibody such as anti-CD8 antibody and anti-CD4 antibody, anti-cytokine antibody such as anti-cancer necrosis factor antibody, anti-endotoxin antibody, single-stranded or double-stranded DNA and the like. Further, of these, two or more kinds of ligands may be insolubilized. The molecular weight of these ligands may be any molecular weight, but from the practical point of view, 1,000,000 or less is easily available.

【0020】リガンドの固定方法 リガンドを被覆担体に不溶化する方法には、多孔質支持
体表面にリガンドと親水性被覆層とを共存させる方法
や、あらかじめ形成した被覆担体表面に被覆層を介して
リガンドを不溶化する方法などがある。例えばリガンド
を溶解した液中に被覆担体を浸漬、或いは該液を噴霧す
ることによってコーティングする方法、化学的に或いは
放射線や電子線を用いてのグラフト法によって共有結合
する方法、或いは化学的方法により官能基を介して共有
結合する方法などがある。この中でグラフト法、官能基
を介しての共有結合法などリガンドを共有結合させるこ
とが使用時のリガンド溶出の危険性がなく、好ましい。
これらの中で、本発明者らの研究によれば、被覆層表面
にリガンドを共有結合させることが吸着能力が高く、製
造も容易であり、最も好ましい。
Method for immobilizing a ligand The method for insolubilizing a ligand in a coated carrier includes a method in which a ligand and a hydrophilic coating layer are allowed to coexist on the surface of a porous support, or a ligand formed on a surface of a previously formed coated carrier via a coating layer. There is a method of insolubilizing. For example, by coating the coated carrier in a liquid in which the ligand is dissolved, or by spraying the liquid, a method of covalently bonding by a chemical method or a grafting method using radiation or an electron beam, or a chemical method. There are methods such as a covalent bond via a functional group. Among these, it is preferable to use a graft method or a covalent bond method via a functional group to covalently bond the ligand, because there is no risk of ligand elution during use.
Among these, according to the research conducted by the present inventors, it is most preferable to covalently bond a ligand to the surface of the coating layer because the adsorption ability is high and the production is easy.

【0021】担体活性化方法 被覆担体に官能基を得る方法の1例としてはハロゲン化
シアン法、エピクロルヒドリン法、エピブロムヒドリン
法、ビスエポキシド法、ブロモアセチルブロミド法、ト
レシルクロライド法、ブロモアセトアミド法等が知られ
ている。具体的にはアミノ基、カルボキシル基、ヒドロ
キシル基、チオール基、酸無水物基、サクシニルイミド
基、塩素基、アルデヒド基、アミド基、エポキシ基、ト
レシル基などがあげられる。この中で加熱滅菌時の安定
性よりエピクロルヒドリン法やエピブロムヒドリン法な
どで誘導されるエポキシ基が特に好ましい例としてあげ
られる。
Carrier Activation Method As an example of a method for obtaining a functional group on the coated carrier, a cyanogen halide method, an epichlorohydrin method, an epibromhydrin method, a bisepoxide method, a bromoacetyl bromide method, a tresyl chloride method, a bromoacetamide method. The law is known. Specific examples include an amino group, a carboxyl group, a hydroxyl group, a thiol group, an acid anhydride group, a succinylimide group, a chlorine group, an aldehyde group, an amide group, an epoxy group and a tresyl group. Of these, epoxy groups derived from the epichlorohydrin method and the epibromhydrin method are particularly preferable because of their stability during heat sterilization.

【0022】リガンド固定量 導入するリガンドの量は特に規定は不要であるが、少な
すぎると吸着能力が低く、多過ぎると使用時にリガンド
が遊離する危険性が生じるため、被覆担体の細孔容積を
含む容積当たり1ng/ml以上100mg/ml以下
であることが良い。更に、あえてより好ましい範囲とし
ては1μg/ml以上100μg/ml以下があげられ
る。
Ligand-immobilized amount The amount of the ligand to be introduced is not particularly specified, but if it is too small, the adsorption capacity is low, and if it is too large, there is a risk of liberation of the ligand at the time of use. It is preferable that the volume is 1 ng / ml or more and 100 mg / ml or less. Further, a more preferable range is 1 μg / ml or more and 100 μg / ml or less.

【0023】用途 被覆担体の用途としては水或いは有機溶剤中の溶解物の
吸着が有り、特に血液などの体液中の蛋白質、糖、核
酸、ホルモン、脂質、サイトカイン等の吸着剤用支持体
として適する。最も好ましくは、臨床における体外循環
治療用選択的或いは特異的吸着剤の担体として使用でき
る。臨床における体外循環治療用選択的或いは特異的吸
着の用途としては、胆汁酸、アミロイド前駆蛋白A、癌
壊死因子、ビリルビン、ビリルビン結合アルブミン、エ
ンドトキシン、抗カルジオリピン抗体、抗アセチルコリ
ンレセプター抗体、低密度及び/または極低密度リポ蛋
白質、スルファチド付着性蛋白質、活性化補体成分、ア
ミロイド蛋白A、免疫複合体、抗血液型抗体、抗血小板
抗体、抗DNA抗体やリウマチ因子等の自己抗体及び/
または該自己抗体を生産する免疫B細胞、T細胞、免疫
グロブリンL鎖、血液凝固第VIII因子、血液凝固第
IX因子、β2 ミクログロブリン等があげられる。
Uses The coated carrier is used for adsorbing a dissolved substance in water or an organic solvent, and is particularly suitable as a support for an adsorbent for proteins, sugars, nucleic acids, hormones, lipids, cytokines and the like in body fluids such as blood. . Most preferably, it can be used as a carrier of a selective or specific adsorbent for clinical extracorporeal circulation treatment. Clinically, the use of selective or specific adsorption for extracorporeal circulation treatment includes bile acid, amyloid precursor protein A, cancer necrosis factor, bilirubin, bilirubin-conjugated albumin, endotoxin, anti-cardiolipin antibody, anti-acetylcholine receptor antibody, low density and / or Or very low density lipoprotein, sulfatide-adhesive protein, activated complement component, amyloid protein A, immune complex, anti-blood group antibody, anti-platelet antibody, auto-antibody such as anti-DNA antibody and rheumatoid factor, and / or
Alternatively, there may be mentioned immune B cells, T cells, immunoglobulin L chains, blood coagulation factor VIII, blood coagulation factor IX, β 2 microglobulin, etc. which produce the autoantibody.

【0024】使用方法 被覆担体にリガンドを不溶化して得られた吸着材は、そ
のまま或いは短く切断し、或いは綿状にして、容器に充
填してカラムとして使用できる。或いは織布、不織布状
に加工した上記吸着材を、例えば該織布や不織布を重ね
て平板状にしたり円筒状に巻いて容器に充填して、カラ
ムとして使用できる。或いは被覆担体にリガンドを不溶
化して得られた吸着材の一部を接着剤等で容器に固定し
て使用することもできる。更に2種以上の吸着材が層状
に、或いはランダムに共存していても良い。容器は吸着
処理される溶液の流入口と流出口とを有し、吸着材が実
質的に流出しない構造で有れば良い。この時、容器の総
内容積に対する吸着材容積の割合は20%以上90%以
下の物が好ましく、より好ましい範囲をあえてあげると
40%以上80%以下が特に優れている。実際の使用に
当たっては血液を直接灌流しても良いし、あらかじめ遠
心分離法或いは膜法等によって分離して得た血漿を灌流
しても良い。この時血液または血漿は連続的に灌流して
も、或いは断続的に灌流しても良い。特に、本発明の被
覆担体にリガンドを不溶化して得られた吸着材は、繊維
を束状にして該束の両端をウレタンやシリコン接着剤等
を用いて束形状を保ち、該容器に固定されている時、血
小板の通過性に優れており、血液を直接灌流する目的に
好ましく使用できる。この時、束の容器への固定は該接
着剤によって成されていても良く、また容器構造を利用
した物理的な方法によって固定されていても良い。
Method of Use The adsorbent obtained by insolubilizing the ligand on the coated carrier can be used as it is, or cut into short pieces, or made into cotton and packed in a container to be used as a column. Alternatively, the adsorbent that has been processed into a woven or non-woven fabric can be used as a column by, for example, stacking the woven or non-woven fabric into a flat plate or rolling it into a cylinder and filling the container. Alternatively, a part of the adsorbent obtained by insolubilizing the ligand in the coated carrier can be fixed to the container with an adhesive or the like before use. Further, two or more kinds of adsorbents may coexist in layers or randomly. The container may have an inflow port and an outflow port for the solution to be adsorbed, and may have a structure in which the adsorbent does not substantially flow out. At this time, the ratio of the adsorbent volume to the total inner volume of the container is preferably 20% or more and 90% or less, and 40% or more and 80% or less is particularly excellent when the more preferable range is taken into consideration. In actual use, blood may be directly perfused, or plasma obtained by previously separating by a centrifugation method or a membrane method may be perfused. At this time, blood or plasma may be continuously perfused or intermittently perfused. In particular, the adsorbent obtained by insolubilizing the ligand in the coated carrier of the present invention is a fiber bundle, and both ends of the bundle are kept in a bundle shape using urethane or silicone adhesive, and fixed to the container. In this case, it has excellent platelet permeability and can be preferably used for the purpose of directly perfusing blood. At this time, the bundle may be fixed to the container by the adhesive, or may be fixed by a physical method using the container structure.

【0025】[0025]

【発明の効果】本発明の被覆担体は、脂質や蛋白質の非
特異吸着がなく血液などの体液との適合性に優れ、更に
多孔質体に均一な貫通孔をもつ中実繊維膜を使うため孔
内へも被吸着物質を含む体液は自由に出入りし内部孔面
積を有効に活用でき、同時に通液抵抗もなく操作出来る
と同時に多くのリガンドを容易に且つ安定に固定でき
る。
The coated carrier of the present invention does not have non-specific adsorption of lipids and proteins, is excellent in compatibility with body fluids such as blood, and uses a solid fiber membrane having a uniform through hole in a porous body. The body fluid containing the substance to be adsorbed into and out of the pores can freely flow in and out, the internal pore area can be effectively utilized, and at the same time, it can be operated without resistance to permeation, and at the same time, many ligands can be immobilized easily and stably.

【実施例】【Example】

【0026】[0026]

【実施例1】高密度ポリエチレン(密度0.968、M
I値5.5、商品名ハイゼックス2208J)を紡口径
10mmの円形紡口を用いて、紡口温度150℃、ポリ
エチレン吐出量8g/分、紡糸距離5m、紡糸冷却温度
25℃、巻き取り張力3gf、巻き取り速度260m/
分、で溶融紡糸した。この時のドラフト比は7,000
であった。紡糸後115℃で2時間アニール処理した。
得られたポリエチレン糸を室温(24℃)にて、1次ロ
ーラー速度1.5m/分、2次ローラー速度2m/分で
冷延伸した。この時の冷延伸倍率は約1.3倍であっ
た。次に連続して108℃、119℃、122℃の3段
階の温度で、それぞれのローラー速度6m/分、7.8
m/分、8.7m/分の延伸速度で熱延伸して延伸開孔
し、中実繊維膜状多孔質構造のポリエチレン製の多孔質
支持体を得た。多孔質支持体の総延伸倍率は5.8倍、
糸径162μm、巻き取り長15kmであった。この多
孔質支持体を、エチレン含量30モル%のエチレン・ビ
ニルアルコールの共重合体をエタノール水溶液に1.0
重量%溶解した液に浸漬し、エチレン・ビニルアルコー
ル共重合体の親水性被覆層を有する被覆担体を得た。被
覆担体は水銀圧入法による平均孔径0.42μm、全細
孔容積4.4ml/g、空孔率80.0%、全表面積2
9.1m2 /g、孔径0.01μm以上10μm以下の
細孔の容積は全細孔容積の93%であった。次に被覆担
体(長さ10cmに切断、800本)を、ジメチルスル
ホキサイド5容、エピクロルヒドリン4容、10N水酸
化ナトリウム水溶液1容の混合液100ml中で、40
℃、2時間反応してエポキシ基を導入した。エポキシ基
を導入した被覆担体に0.1N水酸化ナトリウム水溶液
中でフェニルアラニンを反応させて、フェニルアラニン
固定吸着材を得た。フェニルアラニンの固定量は吸着体
1ml当たり71μ当量であった。フェニルアラニン固
定吸着材は、水銀圧入法による平均孔径0.22μm、
全細孔容積3.9ml/g、全表面積66.1m2
g、浸漬処理前後での重量変化より求めた被覆層の量
3.0×10-3g/m2 であった。非特異吸着性の測定
は、長さ10cmのフェニルアラニン固定吸着材200
本をリウマチ患者血漿6mlに浸漬して、振とう下で3
7℃、2時間反応させておこなった。リウマチ因子はR
Aテスト法にて測定した。各血漿成分の総量の反応前後
の減少率を吸着率として求めた。リウマチ因子、アルブ
ミン、IgG、トランスフェリン、総コレステロール、
フィブリノーゲン、カルシウムイオン、塩素イオンの各
吸着率はそれぞれ50.0%、2.6%、9.1%、
4.2%、1.7%、8.8%、0.3%、0%であ
り、吸着目的物質であるリウマチ因子に対しては高い吸
着性を示し、且つ他の血漿成分の非特異吸着は見られな
かった。
Example 1 High-density polyethylene (density 0.968, M
I value of 5.5, brand name Hi-Zex 2208J) using a circular spinneret with a spinneret diameter of 10 mm, spinning temperature of 150 ° C., polyethylene discharge rate of 8 g / min, spinning distance of 5 m, spinning cooling temperature of 25 ° C., winding tension of 3 gf. , Winding speed 260m /
And melt-spun. The draft ratio at this time is 7,000
Met. After spinning, it was annealed at 115 ° C. for 2 hours.
The obtained polyethylene yarn was cold-drawn at room temperature (24 ° C.) at a primary roller speed of 1.5 m / min and a secondary roller speed of 2 m / min. The cold draw ratio at this time was about 1.3 times. Next, at three consecutive temperatures of 108 ° C., 119 ° C. and 122 ° C., roller speeds of 6 m / min and 7.8, respectively.
A polyethylene porous support having a solid fiber membrane-like porous structure was obtained by hot drawing at a drawing speed of m / min and 8.7 m / min for drawing and opening. The total draw ratio of the porous support is 5.8 times,
The yarn diameter was 162 μm and the winding length was 15 km. This porous support was prepared by adding 1.0% of an ethylene / vinyl alcohol copolymer having an ethylene content of 30 mol% to an aqueous ethanol solution.
The coated carrier having a hydrophilic coating layer of an ethylene / vinyl alcohol copolymer was obtained by immersing in a liquid having a weight% dissolved therein. The coated carrier has an average pore size of 0.42 μm, a total pore volume of 4.4 ml / g, a porosity of 80.0%, and a total surface area of 2 according to the mercury intrusion method.
The volume of pores having a pore size of 9.1 m 2 / g and a pore diameter of 0.01 μm or more and 10 μm or less was 93% of the total pore volume. Then, the coated carrier (cut to a length of 10 cm, 800 pieces) was added to 40 ml of a mixed solution of 5 volumes of dimethyl sulfoxide, 4 volumes of epichlorohydrin and 1 volume of 10N sodium hydroxide aqueous solution in 40 ml.
The reaction was performed at 2 ° C. for 2 hours to introduce an epoxy group. Phenylalanine was reacted with a coated carrier having an epoxy group introduced therein in a 0.1N sodium hydroxide aqueous solution to obtain a phenylalanine-immobilized adsorbent. The fixed amount of phenylalanine was 71 μeq / ml of the adsorbent. The phenylalanine fixed adsorbent has an average pore diameter of 0.22 μm measured by mercury porosimetry.
Total pore volume 3.9 ml / g, total surface area 66.1 m 2 /
The amount of the coating layer was 3.0 × 10 −3 g / m 2 as determined from the change in weight before and after the immersion treatment. Nonspecific adsorption is measured by a phenylalanine fixed adsorbent 200 having a length of 10 cm.
Soak the book in 6 ml of rheumatism patient's plasma and shake for 3
The reaction was carried out at 7 ° C. for 2 hours. Rheumatoid factor is R
It was measured by the A test method. The reduction rate of the total amount of each plasma component before and after the reaction was determined as the adsorption rate. Rheumatoid factor, albumin, IgG, transferrin, total cholesterol,
Fibrinogen, calcium ion, chlorine ion adsorption rate of 50.0%, 2.6%, 9.1%,
4.2%, 1.7%, 8.8%, 0.3%, 0%, showing high adsorbability for rheumatoid factor, which is the target substance for adsorption, and non-specificity of other plasma components. No adsorption was seen.

【0027】[0027]

【実施例2】高密度ポリエチレン(密度0.968、M
I値5.5、商品名ハイゼックス2208J)を紡口径
35mmの円形紡口を用いて、紡口温度150℃、ポリ
エチレン吐出量16g/分、紡糸距離5m、紡糸冷却温
度24℃、巻き取り張力10gf、巻き取り速度400
m/分、で溶融紡糸した。この時のドラフト比は24,
000であった。紡糸後115℃で2時間アニール処理
した。得られたポリエチレン糸を室温(24℃)にて、
1次ローラー速度3.75m/分、2次ローラー速度5
m/分で冷延伸した。この時の冷延伸倍率は約1.3倍
であった。次に連続して108℃、119℃、122℃
の3段階の温度で、それぞれのローラー速度15m/
分、19.5m/分、21.8m/分の延伸速度で熱延
伸して延伸開孔し、中実繊維膜状多孔質構造のポリエチ
レン製の多孔質支持体を得た。多孔質支持体の総延伸倍
率は5.8倍、糸径176μm、巻き取り長15kmで
あった。この多孔質支持体を、ポリヒドロキシエチルメ
タクリレート(分子量約50,000)をメタノール水
溶液に1.0重量%溶解した液に浸漬し、ポリヒドロキ
シエチルメタクリレートの親水性被覆層を有する被覆担
体を得た。浸漬処理前後での重量変化より求めた被覆層
の量は1.8×10-3g/m2 であった。被覆担体(長
さ10cm、100本)を、ジエチルアミンを10%エ
タノール水溶液に30%濃度に溶解した液に浸漬して、
γ線を25kGy照射した。照射後十分に洗浄してジエ
チルアンモニウム基を表面に有する吸着材を得た。多孔
質支持体は水銀圧入法による平均孔径0.17μm、全
細孔容積3.3ml/g、空孔率77.0%、全表面積
49.1m2 /g、孔径0.01μm以上10μm以下
の細孔の容積は全細孔容積の88%であった。実施例1
と同様にして肝不全患者血漿を用いて非特異吸着性の測
定を行ったところ、総ビリルビン、アルブミン、Ig
G、トランスフェリン、総コレステロール、フィブリノ
ーゲン、カルシウムイオン、塩素イオンの各吸着率はそ
れぞれ62.4%、3.1%、3.3%、5.5%、
0.3%、4.7%、0.1%、06%であり、吸着目
的物質である総ビリルビンに対して高い吸着性を示し、
且つ他の血漿成分の非特異吸着は見られなかった。
Example 2 High-density polyethylene (density 0.968, M
I value 5.5, trade name Hi-Zex 2208J) using a circular spinneret with a spinneret diameter of 35 mm, spinning temperature 150 ° C., polyethylene discharge rate 16 g / min, spinning distance 5 m, spinning cooling temperature 24 ° C., winding tension 10 gf , Winding speed 400
Melt spinning was performed at m / min. The draft ratio at this time is 24,
It was 000. After spinning, it was annealed at 115 ° C. for 2 hours. The obtained polyethylene yarn at room temperature (24 ° C),
Primary roller speed 3.75 m / min, secondary roller speed 5
Cold drawing was performed at m / min. The cold draw ratio at this time was about 1.3 times. Next 108 ° C, 119 ° C, 122 ° C continuously
Roller speed of 15m /
Min., 19.5 m / min, and 21.8 m / min, and drawn at a drawing speed to draw holes to obtain a polyethylene porous support having a solid fiber membrane-like porous structure. The total draw ratio of the porous support was 5.8 times, the yarn diameter was 176 μm, and the winding length was 15 km. This porous support was immersed in a solution of polyhydroxyethyl methacrylate (molecular weight: about 50,000) dissolved in 1.0% by weight of an aqueous methanol solution to obtain a coated carrier having a hydrophilic coating layer of polyhydroxyethyl methacrylate. . The amount of the coating layer determined from the weight change before and after the immersion treatment was 1.8 × 10 −3 g / m 2 . The coated carrier (10 cm in length, 100 pieces) was immersed in a solution of diethylamine dissolved in a 10% aqueous ethanol solution at a concentration of 30%,
Irradiation with γ-rays was carried out at 25 kGy. After the irradiation, it was thoroughly washed to obtain an adsorbent having a diethylammonium group on the surface. The porous support has an average pore size of 0.17 μm, a total pore volume of 3.3 ml / g, a porosity of 77.0%, a total surface area of 49.1 m 2 / g, a pore size of 0.01 μm or more and 10 μm or less, as determined by mercury porosimetry. The pore volume was 88% of the total pore volume. Example 1
Non-specific adsorption was measured using plasma of liver failure patient in the same manner as in Example 1. Total bilirubin, albumin, Ig
Adsorption rates of G, transferrin, total cholesterol, fibrinogen, calcium ion, and chloride ion are 62.4%, 3.1%, 3.3%, 5.5%, respectively.
0.3%, 4.7%, 0.1% and 06%, showing high adsorbability for total bilirubin, which is the target substance to be adsorbed,
Moreover, non-specific adsorption of other plasma components was not observed.

【0028】[0028]

【実施例3】実施例1の吸着材700本(充填率35
%)を、内径8mm、長さ10cmのポリカーボネート
製の円筒形の容器に、容器の長さ方向に吸着材を並べて
挿入し、吸着材両端部を容器と共にウレタンで接着固定
した。この時容器両端はウレタンで密閉された。容器に
は別に側面に入り口と出口を設けておいた。入り口と出
口は両端のウレタンで塞がれず、且つお互いに最も離れ
た位置に設けた。以上のようにして吸着器を得た。次に
得られた吸着器を用いて血液の直接灌流性について評価
した。抗凝固剤としてACD−A1/9容の存在下で健
常人血液を採取した。この血液40mlを吸着器に1.
2ml/分で灌流し、吸着器流出液中の血小板数を測定
したところ、血小板の減少率は9.7%と極僅かであ
り、優れた血小板通過性を示した。
Example 3 700 adsorbents of Example 1 (filling rate 35
%) Was adsorbed side by side in a cylindrical container made of polycarbonate having an inner diameter of 8 mm and a length of 10 cm in the length direction of the container, and both ends of the adsorbent were bonded and fixed together with the container by urethane. At this time, both ends of the container were sealed with urethane. The container had a side entrance and an exit. The entrance and exit were not blocked by urethane on both ends, and were located farthest from each other. The adsorber was obtained as described above. Then, the obtained adsorber was used to evaluate the direct perfusion of blood. Normal human blood was collected in the presence of ACD-A1 / 9 as an anticoagulant. 40 ml of this blood was transferred to the adsorber.
When perfusion was performed at 2 ml / min and the number of platelets in the effluent of the adsorber was measured, the reduction rate of platelets was 9.7%, which was extremely low, indicating excellent platelet passage properties.

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】 有機合成高分子材料からなる吸着材用の
中実繊維膜状多孔質担体の表面に高分子被覆層を有する
ことを特徴とする被覆担体。
1. A coated carrier having a polymer coating layer on the surface of a solid fibrous film-like porous carrier for an adsorbent made of an organic synthetic polymer material.
【請求項2】 高分子被覆層がヒドロキシル基を有する
親水性合成化合物である請求項1記載の被覆担体。
2. The coated carrier according to claim 1, wherein the polymer coating layer is a hydrophilic synthetic compound having a hydroxyl group.
【請求項3】 高分子被覆層の量が10-5g/m2 以上
1g/m2 以下である請求項2記載の被覆担体。
3. The coated carrier according to claim 2, wherein the amount of the polymer coating layer is 10 −5 g / m 2 or more and 1 g / m 2 or less.
【請求項4】 リガンド物質が親水性被覆層と共有結合
することで不溶化されている請求項1記載の被覆担体。
4. The coated carrier according to claim 1, wherein the ligand substance is insolubilized by covalently bonding with the hydrophilic coating layer.
【請求項5】 平均孔径が0.01μm以上10μm以
下の細孔を有する、有機合成高分子材料からなる吸着材
用の請求項1記載の被覆担体。
5. The coated carrier according to claim 1, which is for an adsorbent made of an organic synthetic polymer material having pores having an average pore diameter of 0.01 μm or more and 10 μm or less.
【請求項6】 全表面積が1m2 /g以上500m2
g以下である請求項1記載の被覆担体。
6. The total surface area is 1m 2 / g or more 500m 2 /
The coated carrier according to claim 1, which is not more than g.
【請求項7】 孔径0.01μm以上10μm以下の細
孔の容積が全細孔容積の40%以上である請求項1記載
の被覆担体。
7. The coated carrier according to claim 1, wherein the volume of pores having a pore diameter of 0.01 μm or more and 10 μm or less is 40% or more of the total pore volume.
【請求項8】 ポリオレフィンから成る請求項1記載の
被覆担体。
8. The coated carrier according to claim 1, which comprises a polyolefin.
JP11426893A 1993-04-19 1993-04-19 Coated carrier Expired - Fee Related JP3353945B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11426893A JP3353945B2 (en) 1993-04-19 1993-04-19 Coated carrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11426893A JP3353945B2 (en) 1993-04-19 1993-04-19 Coated carrier

Publications (2)

Publication Number Publication Date
JPH06296859A true JPH06296859A (en) 1994-10-25
JP3353945B2 JP3353945B2 (en) 2002-12-09

Family

ID=14633561

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11426893A Expired - Fee Related JP3353945B2 (en) 1993-04-19 1993-04-19 Coated carrier

Country Status (1)

Country Link
JP (1) JP3353945B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004098680A1 (en) * 2003-05-08 2004-11-18 Kaneka Corporation Low density lipoprotein/fibrinogen adsorbent and adsorption apparatus capable of whole blood treatment
JP2008136757A (en) * 2006-12-05 2008-06-19 Asahi Kasei Kuraray Medical Co Ltd Filter material, device and method for suppressing inflammatory cytokine production
JP2017192875A (en) * 2016-04-18 2017-10-26 学校法人福岡大学 Protein adsorbent

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2720665C (en) 2008-04-18 2013-12-17 Nikkiso Co., Ltd. Adsorbent formed from polyarylate for the removal of blood cells
JP5188280B2 (en) * 2008-06-12 2013-04-24 日機装株式会社 Blood cell removal module

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004098680A1 (en) * 2003-05-08 2004-11-18 Kaneka Corporation Low density lipoprotein/fibrinogen adsorbent and adsorption apparatus capable of whole blood treatment
JPWO2004098680A1 (en) * 2003-05-08 2006-07-13 株式会社カネカ Adsorbent and adsorber for low density lipoprotein and fibrinogen capable of whole blood treatment
JP4578405B2 (en) * 2003-05-08 2010-11-10 株式会社カネカ Adsorbent and adsorber for low density lipoprotein and fibrinogen capable of whole blood treatment
JP2008136757A (en) * 2006-12-05 2008-06-19 Asahi Kasei Kuraray Medical Co Ltd Filter material, device and method for suppressing inflammatory cytokine production
JP2017192875A (en) * 2016-04-18 2017-10-26 学校法人福岡大学 Protein adsorbent

Also Published As

Publication number Publication date
JP3353945B2 (en) 2002-12-09

Similar Documents

Publication Publication Date Title
JP6243924B2 (en) Filter device combining beads and fibers
Zeng et al. Membrane chromatography: preparation and applications to protein separation
US6238795B1 (en) Surface modified polymer beads
JP6922006B2 (en) How to purify biomolecules in a sample
CN102317523B (en) Functionalized nonwoven article
JP6105471B2 (en) Size selective polymer system
EP0341413B2 (en) An adsorber module and adsorber apparatus for whole blood treatment
JP5784008B2 (en) Ligand immobilization substrate and method for producing the same
JP3353945B2 (en) Coated carrier
JP4997770B2 (en) Adsorber
JPH06296860A (en) Porous support and adsorption material
Jin et al. Surface modifying of microporous PTFE capillary for bilirubin removing from human plasma and its blood compatibility
WO2012068442A1 (en) High-surface area fibers and nonwoven membranes for use in bioseparations
JP2814399B2 (en) Adsorber for whole blood processing
JP5784132B2 (en) Ligand immobilization substrate and production method thereof, specific cell separation material, and blood treatment device
JPH0615167A (en) Porous separating membrane
JPH02209155A (en) Porous adsorbent for beta2-microglobulin
JP2568846B2 (en) Myoglobin adsorbent
JP7459449B2 (en) Adsorption material for soluble tumor necrosis factor receptors
JP2010235496A (en) Immunoglobulin g separator
JPH08164202A (en) Liquid processing column and liquid processing method using this column
JP2023081326A (en) Blood purification carrier and blood purification column
JPH043988B2 (en)
JPS63283747A (en) Myoglobin adsorption material
JPS60126165A (en) Blood compatible adsorbing material

Legal Events

Date Code Title Description
S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080927

Year of fee payment: 6

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090927

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090927

Year of fee payment: 7

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090927

Year of fee payment: 7

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100927

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110927

Year of fee payment: 9

LAPS Cancellation because of no payment of annual fees